Altwijri RJ, Alsirhy E. Uveitis glaucoma hyphema syndrome as a result of glaucoma implant: A case report. World J Clin Cases 2024; 12(28): 6217-6221 [DOI: 10.12998/wjcc.v12.i28.6217]
Corresponding Author of This Article
Rahaf Jalal Altwijri, MBBS, Doctor, Department of Ophthalmology, King Saud University Hospital, Sufyan Bin Waheb Street, Riyadh 13211, Saudi Arabia. altwijrirahaf@gmail.com
Research Domain of This Article
Ophthalmology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Oct 6, 2024; 12(28): 6217-6221 Published online Oct 6, 2024. doi: 10.12998/wjcc.v12.i28.6217
Uveitis glaucoma hyphema syndrome as a result of glaucoma implant: A case report
Rahaf Jalal Altwijri, Ehab Alsirhy
Rahaf Jalal Altwijri, Department of Ophthalmology, King Saud University Hospital, Riyadh 13211, Saudi Arabia
Ehab Alsirhy, Glaucoma and Cataract, Department of Ophthalmology, King Abdulaziz University Hospital, King Saud University, Riyadh 15112, Saudi Arabia
Author contributions: Altwijri RJ and Alsirhy E contributed to conception, design and writing of this case report as well as to the underlying data collection from the patient’s clinical records and the relevant peer-reviewed literature.
Informed consent statement: Informed written consent was obtained from the patients for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rahaf Jalal Altwijri, MBBS, Doctor, Department of Ophthalmology, King Saud University Hospital, Sufyan Bin Waheb Street, Riyadh 13211, Saudi Arabia. altwijrirahaf@gmail.com
Received: February 4, 2024 Revised: June 20, 2024 Accepted: July 19, 2024 Published online: October 6, 2024 Processing time: 190 Days and 10.4 Hours
Abstract
BACKGROUND
Glaucoma is caused by increased intraocular pressure (IOP) that damages the optic nerve, leading to blindness. The Ahmed glaucoma valve (AGV) is a glaucoma drainage implant device that is used in glaucoma patients with uncontrolled IOP. A possible complication after any ocular surgery however is hyphema, which can itself progress to uveitis glaucoma hyphema (UGH) syndrome on rare occasions. UGH syndrome has not yet been reported as a complication of AGV implantation.
CASE SUMMARY
Here, we have reported a case of a 55-year-old female who developed both hyphema and pigmentation as a result of AGV implantation. We confirmed UGH syndrome secondary to AGV implantation after the patient underwent another surgery to shorten and reposition the AGV tube. After the second surgery, the patient’s IOP was reduced, and she had a clear cornea and no signs of hyphema.
CONCLUSION
This first report of UGH syndrome as a complication of AGV implantation reminds clinicians that frequent follow-up is paramount.
Core Tip: Glaucoma is caused by increased intraocular pressure that damages the optic nerve leading to blindness. Intraocular pressure can be relieved by implanting a drainage device. We report here a case of a 55-year-old female who developed uveitis glaucoma hyphema (UGH) syndrome as a complication after drainage implantation surgery. After treatment with a second surgery to shorten the drainage tube, the patient recovered well with a decrease in intraocular pressure and clearing of the hyphema. This represents the first report of UGH syndrome occurring after the implantation of a drainage device to treat glaucoma.
